Teva Ready to Divest Operations to Win Regulatory Nod for Mylan Buy

In a press release via PharmaVoice.com, “Generic drugmaker Teva Pharmaceutical Industries Ltd said it could “promptly” divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV…Teva plans to work...

Roche Holding AG Acquires CAPP Medical

Roche Holding AG has acquired CAPP Medical according to a press release via Zacks.com.  “The acquisition will further strengthen Roche’s diagnostics portfolio. As per Roche, next-generation sequencing assays have the ability to significantly advance the duration...

Boston Scientific Agrees to Pay $62.5 Million for Xlumena

Boston Scientific has agreed to a $62.5 million deal with Xlumena and its Axios line of biliary devices, putting at least another $12.5 million on the table in potential milestones, according to an article via MassDevice.com.  The move establishes both Boston...

A Look at the Top Pharma M&A Deals of 2014

    Mergers and acquisitions of biopharma companies saw a huge increase in 2014, with the largest deal more than quadrupling the top deal of 2013, and the top 10 deals all exceeding a whopping $10 billion. Take a look at the top 10 mergers and acquisitions...